Tag : Anticoagulant


Risk-Score Insights on How DOACs Vary in Upper GI Bleed Risk

Adding a proton-pump inhibitor to oral anticoagulation can defend against gastrointestinal bleeding, but with varying success, depending on which oral anticoagulant, especially in high-risk patients....

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this...

Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!

The Authors’ reply Thank you for your kind feedback1. The authors do not disagree with the confusion around the term ‘non-valvular atrial fibrillation’. Our attempt...

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World